Earnings call ClearPoint Neuro reported Q3 2025 revenue of $8.9M, up 9% YoY, with gross margin expanding to 63%. Management reaffirmed FY25 revenue guidance of $36M–$38M and issued preliminary 2026 ...
COLUMBIA, SC, UNITED STATES, March 26, 2025 / EINPresswire.com / -- ClearPoint Health invites benefit advisors, human resources professionals, and employers to a free webinar event celebrating the ...
COLUMBIA, S.C.--(BUSINESS WIRE)--ClearPoint Health (“ClearPoint”) is a medical stop-loss captive platform for small and mid-sized employers. ClearPoint’s platform empowers employers and benefit ...
ClearPoint Neuro's progress on its four-pillar strategy continues despite a challenging operating environment, with an increasing number of partners and hospital sites featuring its equipment. The ...
ClearPoint Neuro CLPT recently unveiled the development of its proprietary Robotic Neuro-Navigation System, a move that positions the company to contribute to robotics, neurosurgery, and advanced drug ...
Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire ...
ClearPoint Neuro (NASDAQ:CLPT) reported its Q3 2025 financial results on November 6, revealing a mixed performance. The company posted a revenue of $8.9 million, falling short of the $9.8 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback